In ovarian cancer cells, CXCL12 and its receptor CXCR4 increased the production of integrin-1β and vascular endothelial growth factor-C (VEGF-C), activating tumor vasculature in ovarian cancer (Predescu et al., 2019). Here, VEGFC is linked to ovarian cancer.